Senior insider sale
Chief Financial Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$2.53M
312.86K shares
What this filing means
DELFINI LISA plans to sell 312.86K shares of TREVI THERAPEUTICS, INC. valued at approximately $2.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/27/2025ACC: 0001972481-25-000182
Officer· Chief Financial Officer
Since Aug 2021
312.86K
Shares to sell
$2.53M
Approx. market value
325.29K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Option Exercise
Cash
2/26/2023
259.58KRestricted Stock Units
Cash
2/15/2023
65.71KTotal acquired325.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2023 | Option Exercise Cash | 259.58K | — |
2/15/2023 | Restricted Stock Units Cash | 65.71K | — |
| Total | 325.29K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
312.86K
Market value
$2.53M
8/27/2025
Total
Units
312.86K
Value
$2.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/27/2025 | 312.86K | $2.53M | Nasdaq | Planned |
| Total | 312.86K | $2.53M | ||